Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Cancer Screening Market Outlook

The global cancer screening market is expected to grow in the forecast period of 2024-2032 at a CAGR of 9%.

Cancer Screening Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Increasing Focus on Early Detection and Prevention of Cancer Aiding the Growth of Cancer Screening Industry

The cancer screening industry is being aided by the surging cancer cases across the world. The development of superior imaging to identify the cancerous tissues of different cancer types is also propelling the market growth. As cancer is one of the leading causes of death worldwide, the demand for early detection and cure of the chronic disease is rising. Screenings are increasingly used to detect cancers and to reduce the death rates from the illness. The Asia Pacific region is expected to witness significant growth due to the rising cancer cases attributed to unhealthy lifestyles and the rising consumption of tobaccos and other carcinogenic products. Moreover, the increasing penetration of technological advancements and the improving healthcare infrastructure, along with the rising awareness of various chronic diseases in the emerging economies, such as India, China, Indonesia, and Brazil, among others, are lubricating the market growth.

Geographically, North America holds a significant share of the market due to the surging cancer cases in the country as well as increasing research and development (R&D) to diagnose and treat cancer effectively. Moreover, the advancement of biotechnology and the presence of global players in the region are further fuelling the market growth. The Control of Centre of Diseases and Prevention (CDC) of the United States offers various programs, such as National Breast and Cervical Early Cancer Detection Program (NBCCEDP), through which cost-effective screening is offered to the patients. Such initiatives are lubricating the industry growth.

Cancer Screening: Market Segmentation

Cancer screening is a test that can aid in detecting cancer at an early stage before symptoms appear. It decreases the chance of the cancerous cells to grow abnormally and reduces the mortality rates of the person. Each type of cancer has its screening test, which can aid in detecting cancer in its early stages.

Cancer Screening Market By Segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on the cancer types, the industry is divided into:

  • Lung Cancer
  • Blood Cancer
  • Bone Cancer
  • Gall Bladder Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Breast Cancer
  • Others

The major techniques of cancer screening are:

  • Imaging Techniques
  • CT Scan
  • MRI
  • Others
  • Endoscopy
  • Colonoscopy
  • Sigmoidoscopy
  • Others
  • Biopsy and Cytology Tests
  • Needle Biopsy
  • CT-Guided Biopsy
  • Others
  • Genomic and Molecular tests
  • Next Generation Sequencing (NGS)
  • RT- PCR
  • Others

The market can be broadly categorised on the basis of stage by:

  • TNM Stages
  • Stages 0, 1, 2, 3, 4
  • Prognostic Factors
  • Others

On the basis of gender, the market is segmented into:

  • Men 
  • Women

The EMR report looks into the regional markets of cancer screening like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Cancer Screening Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Technological Advancements to Aid the Growth of the Cancer Screening Industry

Screening can detect cancer at an early stage, due to which the treatment can be started in the early stages, which can reduce the risk of death. The rising cases of death due to cancer is driving the market growth. Increasing research and development (R&D) to create effective treatments and early diagnosis of cancer is further propelling the market growth. Innovative technologies such as positron emission mammography, spectroscopy-enhanced colonoscopy, and hyperpolarisation MRI, among others, are increasing the efficiency of screening, consequently aiding the industry growth. Moreover, further research and innovations in the field of leukaemia and ovarian cancer, which are currently difficult to screen, are further expected to propel the industry growth in the forecast period.

The use of artificial intelligence (AI) to improve the accuracy, the speed of diagnosis, and reduce health disparity in a low-resource setting is driving the market growth. As artificial intelligence can aid clinical decision making, identify specific gene mutations, and improve MRI guided biopsy, they are used in research by various organisations, such as National Cancer Institute, which is providing further impetus to the market growth. Moreover, the use of advanced technology such as real-time data analysis, computation and digital pathology, and molecular diagnostics to enable pattern recognition in population data to predict treatment response, survival, and the likelihood of recurrence are further anticipated to aid the market growth.

Key Industry Players in the Global Cancer Screening Market

The report presents a detailed analysis of the following key players in the global cancer screening market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • DiaSorin S.p.A.
  • Epigenomics AG
  • Techlab, Inc.
  • Positive Biosciences Limited
  • MedGenome Labs Ltd
  • 20/20 GeneSystems
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Cancer Type
  • Technique
  • Stage
  • Gender
  • Region
Breakup by Type
  • Lung Cancer
  • Blood Cancer
  • Bone Cancer
  • Gall Bladder Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Breast Cancer
  • Others
Breakup by Technique
  • Imaging Techniques
  • Endoscopy
  • Biopsy and Cytology Tests
  • Genomic and Molecular tests
Breakup by Stage
  • TNM Stages
  • Stages 0, 1, 2, 3, 4
  • Prognostic Factors
  • Others
Breakup by Gender
  • Men
  • Women
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • DiaSorin S.p.A.
  • Epigenomics AG
  • Techlab, Inc.
  • Positive Biosciences Limited
  • MedGenome Labs Ltd
  • 20/20 GeneSystems
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!

Key Questions Answered in the Report

The cancer screening market is projected to grow at a CAGR of 9% between 2024 and 2032.

The industry is being aided by the surge of cancer cases worldwide and the increasing efforts and favourable government initiatives to prevent cancer by diagnosing them at early stages.

The industry is driven by the technological advancements, increasing research and development (R&D) to prevent and detect cancer, and the use of advanced technology such as artificial intelligence (AI) and real-time data analytics to detect cancer efficiently.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest share in the market.

The major cancer types of cancer screening in the industry are lung cancer, blood cancer, bone cancer, gall bladder cancer, testicular cancer, thyroid cancer, and breast cancer, among others.

The significant techniques in the market are imaging techniques, endoscopy, biopsy and cytology tests, and genomic and molecular tests.

The leading stages of cancer screening in the market are TNM stages, stages 0, 1, 2, 3, 4, and prognostic factors, among others.

The dominant genders in the industry are men and women.

The major players in the industry are DiaSorin S.p.A., Epigenomics AG, Techlab, Inc., Positive Biosciences Limited, MedGenome Labs Ltd, and 20/20 GeneSystems, among others.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Locations


United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124